| Name | Gliclazide |
| Previous identifier | 325238000 |
| VTM identifier date | 6 Feb 2023 |
| Virtual Medicinal Products | |
|---|---|
| Gliclazide 100mg/5ml oral suspension | |
| Gliclazide 120mg/5ml oral suspension | |
| Gliclazide 160mg/5ml oral suspension | |
| Gliclazide 160mg tablets | |
| Gliclazide 20mg/5ml oral suspension | |
| Gliclazide 30mg/5ml oral suspension | |
| Gliclazide 30mg modified-release tablets | |
| Gliclazide 40mg/5ml oral suspension | |
| Gliclazide 40mg tablets | |
| Gliclazide 50mg/5ml oral suspension | |
| Gliclazide 60mg/5ml oral suspension | |
| Gliclazide 60mg modified-release tablets | |
| Gliclazide 80mg/5ml oral suspension | |
| Gliclazide 80mg tablets | |
dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.